Current Management and Unmet Needs in Alopecia Areata: Viewpoint From a Malaysian Perspective
Authors:
- Azura Mohd AffandiAAAzura Mohd Affandi
- Adawiyah JamilAJAdawiyah Jamil
- Noor Zalmy AzizanNANoor Zalmy Azizan
- Felix Boon-Bin YapFYFelix Boon-Bin Yap
- Kin Fon LeongKLKin Fon Leong
- Agnes Yoke Hui HengAHAgnes Yoke Hui Heng
- Siti NuraihanSNSiti Nuraihan
- Wooi Chiang TanWTWooi Chiang Tan
- Latha SelvarajahLSLatha Selvarajah
- Teeba RajaTRTeeba Raja
- Evelyn Wen Yee YapEYEvelyn Wen Yee Yap
- Peter Wee Beng Ch'NGPCPeter Wee Beng Ch'NG
Open Access
- 21 September 2026
- journal article
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 9, e89583
Abstract
Alopecia areata (AA) is a chronic, immune-mediated disease characterized by nonscarring hair loss and a substantial clinical and psychosocial burden, yet it is still widely perceived as a purely cosmetic concern. In this viewpoint, we draw on the available Malaysian studies, selected international evidence, and our collective clinical experience to propose that AA warrants greater clinical, research, and policy attention in Malaysia. Malaysia-specific evidence remains limited and is derived largely from retrospective, single-center studies; nonetheless, the available data point to variable disease presentation, inconsistent use of standardized severity assessment, reliance on conventional therapies, substantial loss to follow-up, and a meaningful psychosocial impact among affected patients. Current local management appears to rely mainly on conventional therapies, while access to advanced therapies such as Janus kinase inhibitors remains constrained by affordability and reimbursement challenges. We therefore call for 5 priorities: strengthening Malaysia-specific epidemiological and real-world evidence, including through a national AA registry; adopting standardized disease-assessment tools in clinical studies and routine practice; integrating psychosocial support into AA care pathways; developing locally relevant clinical guidance; and improving public, clinician, and policymaker awareness that AA is a medical condition rather than a cosmetic concern. Together, these steps would support earlier diagnosis, more equitable access to effective treatment, and holistic, patient-centered care for adults and children living with AA in Malaysia.Keywords
This publication has 46 references indexed in Scilit:
- Alopecia Areata Treatment: Past, Present, and FutureDermatological Reviews, 2024
- Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in EuropeDermatology and Therapy, 2024
- Treatment Patterns for Alopecia Areata in the USJAMA Dermatology, 2023
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)Dermatology and Therapy, 2023
- Eyebrow and Eyelash Alopecia: A Clinical ReviewAmerican Journal of Clinical Dermatology, 2022
- Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature ReviewDermatology and Therapy, 2021
- Comorbidities in alopecia areata: A systematic review and meta-analysisJournal of the American Academy of Dermatology, 2019
- Psychosomatic aspects of alopecia areataClinics in Dermatology, 2018
- Objective outcome measures: Collecting meaningful data on alopecia areataJournal of the American Academy of Dermatology, 2018
- Die Wechselbeziehung zwischen Arzt, Friseur und Medien im Management von HaarverlustDie Dermatologie, 2000